Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Yosuke Yasuda, Soichiro Yoshida, Shugo Yajima, Yoshitomo Yamaguchi, Wei Chen, Hajime Tanaka, Hiroyuki Sato, Akihiro Hirakawa, Kotaro Suzuki, Kensaku Ishihara, Ichiro Yonese, Takashi Tamiya, Keita Izumi, Takanobu Yamamoto, Yuki Nakamura, Sho Uehara, Masahiro Toide, Saori Araki, Naoko Kawamura, Touko Asano, Ryoji Takazawa, Noboru Numao, Yasuhisa Fujii
Format: Artículo Open Access
Published: Wiley 2026
Subjects:
The Prostate
Online Access:https://onlinelibrary.wiley.com/doi/10.1002/pros.70159
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View

Internet

https://onlinelibrary.wiley.com/doi/10.1002/pros.70159

Similar Items

  • Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First‐Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real‐World Study ( YUSHIMA Study)
    by: Rie Muta, et al.
    Published: (2026)
  • Real‐World Outcomes of First‐Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment ( YUSHIMA Study)
    by: Tomoki Kimura, et al.
    Published: (2025)
  • Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone‐Sensitive Prostate Cancer: YUSHIMA Study
    by: Yosuke Yasuda, et al.
    Published: (2025)
  • Clinical Features and Risk Factors of Enfortumab Vedotin–Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study ( YUSHIMA Study)
    by: Takahiko Soma, et al.
    Published: (2025)
  • Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum‐Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study
    by: Hiroki Shimoda, et al.
    Published: (2026)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs